Bristol-Myers Squibb has allied with biotech accelerator BioMotiv. The deal sets Bristol-Myers up to found and fund biotechs with BioMotiv before going on to acquire them outright once a preclinical candidate is identified.
{iframe}https://www.fiercebiotech.com/biotech/bristol-myers-teams-biomotiv-to-build-and-buy-biotechs{/iframe}